A detailed history of Sg Americas Securities, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Sg Americas Securities, LLC holds 14,087 shares of PRTA stock, worth $214,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,087
Previous 54,572 74.19%
Holding current value
$214,404
Previous $1.13 Million 79.04%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$16.73 - $24.79 $677,314 - $1 Million
-40,485 Reduced 74.19%
14,087 $236,000
Q2 2024

Jul 12, 2024

BUY
$19.54 - $26.15 $739,628 - $989,829
37,852 Added 226.39%
54,572 $1.13 Million
Q1 2024

May 06, 2024

SELL
$24.75 - $40.66 $2.95 Million - $4.84 Million
-119,137 Reduced 87.69%
16,720 $414,000
Q4 2023

Jan 12, 2024

BUY
$32.31 - $52.32 $1.4 Million - $2.27 Million
43,363 Added 46.88%
135,857 $4.94 Million
Q3 2023

Oct 13, 2023

BUY
$47.3 - $70.6 $4.21 Million - $6.28 Million
88,939 Added 2501.8%
92,494 $4.46 Million
Q2 2023

Jul 10, 2023

SELL
$48.26 - $78.59 $5.11 Million - $8.32 Million
-105,846 Reduced 96.75%
3,555 $243,000
Q1 2023

Apr 28, 2023

BUY
$46.97 - $58.27 $1.44 Million - $1.78 Million
30,629 Added 38.88%
109,401 $5.3 Million
Q4 2022

Feb 02, 2023

SELL
$52.05 - $65.0 $2.96 Million - $3.69 Million
-56,816 Reduced 41.9%
78,772 $4.75 Million
Q3 2022

Oct 31, 2022

SELL
$25.16 - $60.63 $478,040 - $1.15 Million
-19,000 Reduced 12.29%
135,588 $8.22 Million
Q2 2022

Jul 29, 2022

BUY
$22.73 - $39.98 $251,893 - $443,058
11,082 Added 7.72%
154,588 $4.2 Million
Q1 2022

Apr 29, 2022

SELL
$30.27 - $49.22 $343,170 - $558,007
-11,337 Reduced 7.32%
143,506 $5.25 Million
Q4 2021

Feb 07, 2022

BUY
$42.11 - $73.26 $1.63 Million - $2.84 Million
38,767 Added 33.4%
154,843 $7.65 Million
Q3 2021

Nov 01, 2021

BUY
$48.2 - $78.89 $5.11 Million - $8.37 Million
106,056 Added 1058.44%
116,076 $8.27 Million
Q2 2021

Aug 12, 2021

SELL
$21.63 - $57.65 $11,247 - $29,978
-520 Reduced 4.93%
10,020 $515,000
Q1 2021

May 13, 2021

SELL
$11.0 - $28.24 $31,229 - $80,173
-2,839 Reduced 21.22%
10,540 $265,000
Q4 2020

Feb 04, 2021

BUY
$10.12 - $13.94 $135,395 - $186,503
13,379 New
13,379 $161,000
Q3 2020

Nov 09, 2020

SELL
$9.93 - $13.47 $120,927 - $164,037
-12,178 Closed
0 $0
Q2 2020

Jul 20, 2020

SELL
$9.56 - $12.51 $41,633 - $54,481
-4,355 Reduced 26.34%
12,178 $127,000
Q1 2020

Apr 30, 2020

BUY
$7.54 - $15.77 $55,788 - $116,682
7,399 Added 81.01%
16,533 $177,000
Q4 2019

Jan 28, 2020

BUY
$7.48 - $17.01 $68,322 - $155,369
9,134 New
9,134 $145,000
Q2 2019

Jul 29, 2019

SELL
$8.85 - $12.49 $82,871 - $116,956
-9,364 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$10.32 - $14.49 $96,636 - $135,684
9,364 New
9,364 $114,000
Q3 2018

Nov 06, 2018

SELL
$12.7 - $15.79 $89,027 - $110,687
-7,010 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$10.99 - $44.21 $10,891 - $43,812
991 Added 16.46%
7,010 $102,000
Q1 2018

May 03, 2018

BUY
$27.95 - $45.04 $36,670 - $59,092
1,312 Added 27.87%
6,019 $221,000
Q4 2017

Jan 24, 2018

SELL
$35.44 - $63.76 $79,208 - $142,503
-2,235 Reduced 32.2%
4,707 $176,000
Q3 2017

Nov 07, 2017

BUY
$53.83 - $67.75 $373,687 - $470,320
6,942
6,942 $450,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.